357 related articles for article (PubMed ID: 31299360)
21. Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer.
Thériault BL; Pajovic S; Bernardini MQ; Shaw PA; Gallie BL
Int J Cancer; 2012 Apr; 130(8):1844-54. PubMed ID: 21618518
[TBL] [Abstract][Full Text] [Related]
22. CST2 promotes cell proliferation and regulates cell cycle by activating Wnt-β-catenin signalling pathway in serous ovarian cancer.
Wang X; Zhao S; Guo Y; Wang C; Han S; Wang X
J Obstet Gynaecol; 2024 Dec; 44(1):2363515. PubMed ID: 38864487
[TBL] [Abstract][Full Text] [Related]
23. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer.
Ma S; Deng X; Yang Y; Zhang Q; Zhou T; Liu Z
Biomed Pharmacother; 2018 Dec; 108():1686-1693. PubMed ID: 30372871
[TBL] [Abstract][Full Text] [Related]
24. Long noncoding RNA NEAT1, regulated by LIN28B, promotes cell proliferation and migration through sponging miR-506 in high-grade serous ovarian cancer.
Yong W; Yu D; Jun Z; Yachen D; Weiwei W; Midie X; Xingzhu J; Xiaohua W
Cell Death Dis; 2018 Aug; 9(9):861. PubMed ID: 30154460
[TBL] [Abstract][Full Text] [Related]
25. [Expression and function of long intergenic non-protein coding RNA-regulator of reprogramming in high-grade ovarian serous cancer].
Jiang HH; Lou YH; Wang XY; Han Y; Cui ZM
Zhonghua Fu Chan Ke Za Zhi; 2016 Dec; 51(12):921-927. PubMed ID: 28057128
[No Abstract] [Full Text] [Related]
26. Long noncoding RNA HOTTIP is a significant indicator of ovarian cancer prognosis and enhances cell proliferation and invasion.
Zou T; Wang PL; Gao Y; Liang WT
Cancer Biomark; 2019; 25(2):133-139. PubMed ID: 30452402
[TBL] [Abstract][Full Text] [Related]
27. Role of long non-coding RNA SNHG1 in occurrence and progression of ovarian carcinoma.
Ge J; Wu XM; Yang XT; Gao JM; Wang F; Ye KF
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):329-335. PubMed ID: 29424921
[TBL] [Abstract][Full Text] [Related]
28. Long Non-Coding RNA HAND2-AS1 Acts as a Tumor Suppressor in High-Grade Serous Ovarian Carcinoma.
Gokulnath P; de Cristofaro T; Manipur I; Di Palma T; Soriano AA; Guarracino MR; Zannini M
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517089
[TBL] [Abstract][Full Text] [Related]
29. Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer.
Hooda J; Novak M; Salomon MP; Matsuba C; Ramos RI; MacDuffie E; Song M; Hirsch MS; Lester J; Parkash V; Karlan BY; Oren M; Hoon DS; Drapkin R
Cancer Res; 2019 Feb; 79(4):760-772. PubMed ID: 30563893
[TBL] [Abstract][Full Text] [Related]
30. Higher CXCL16 exodomain is associated with aggressive ovarian cancer and promotes the disease by CXCR6 activation and MMP modulation.
Mir H; Kaur G; Kapur N; Bae S; Lillard JW; Singh S
Sci Rep; 2019 Feb; 9(1):2527. PubMed ID: 30792527
[TBL] [Abstract][Full Text] [Related]
31. The role of long non-coding RNA PCA3 in epithelial ovarian carcinoma tumorigenesis and progression.
Liu Y; Zong ZH; Guan X; Wang LL; Zhao Y
Gene; 2017 Oct; 633():42-47. PubMed ID: 28864116
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of long non‑coding RNA CCEPR is associated with poor prognosis and contributes to the progression of ovarian cancer through regulating the Wnt/β‑catenin signaling pathway.
Chen Z; Zhu Y; Fan X; Liu Y; Feng Q
Mol Med Rep; 2020 Apr; 21(4):1950-1958. PubMed ID: 32319633
[TBL] [Abstract][Full Text] [Related]
33. LncRNA EBIC promoted proliferation, metastasis and cisplatin resistance of ovarian cancer cells and predicted poor survival in ovarian cancer patients.
Xu QF; Tang YX; Wang X
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4440-4447. PubMed ID: 30058681
[TBL] [Abstract][Full Text] [Related]
34. SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis.
Yang M; Xie X; Ding Y
Oncol Rep; 2016 Mar; 35(3):1796-806. PubMed ID: 26750614
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-625-3p improved proliferation and involved chemotherapy resistance via targeting PTEN in high grade ovarian serous carcinoma.
Zhong L; Liu X; Wang L; Liu Y; Zhang D; Zhao Y
J Ovarian Res; 2022 Jan; 15(1):7. PubMed ID: 35027053
[TBL] [Abstract][Full Text] [Related]
36. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
Xia S; Ji R; Zhan W
BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
[TBL] [Abstract][Full Text] [Related]
38. Long Noncoding RNA MNX1-AS1 Knockdown Inhibits Cell Proliferation and Migration in Ovarian Cancer.
Lv Y; Li H; Li F; Liu P; Zhao X
Cancer Biother Radiopharm; 2017 Apr; 32(3):91-99. PubMed ID: 28414551
[TBL] [Abstract][Full Text] [Related]
39. High expression of SLC7A1 in high-grade serous ovarian cancer promotes tumor progression and is involved in MAPK/ERK pathway and EMT.
You S; Han X; Xu Y; Sui L; Song K; Yao Q
Cancer Med; 2024 May; 13(10):e7217. PubMed ID: 38752472
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA BLACAT1 promotes cell proliferation, migration and invasion in cervical cancer through activation of Wnt/β-catenin signaling pathway.
Wang CH; Li YH; Tian HL; Bao XX; Wang ZM
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3002-3009. PubMed ID: 29863244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]